Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Accepting FNA Samples for Analysis with miRNA Lung Cancer Diagnostic

Premium

Rosetta Genomics this week announced that it has begun to accept fine-needle aspirate cell block samples for analysis using its miRview Squamous test, which uses microRNA signatures to differentiate squamous from non-squamous non-small-cell lung cancer.

"FNA is a less invasive method to obtain tumor cells compared with tumor resections or biopsies … [enabling] patients and physicians to benefit from a highly accurate diagnostic assay without having to undergo a more invasive procedure," the company said.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.